Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2003 07:25 ET | Source: BioXell SpA

BioXell Initiates Phase II Clinical Trial with BXL-628 in Benign Prostatic Hyperplasia

MILAN, Italy, March 27, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company, today announced that it has initiated recruitment for the Phase II trial of its novel lead compound,...